New Jersey’s chief judge of mass-tort litigation has refused to certify a consumer class action on behalf of more than 30 million people nationwide who may have suffered heart damage from taking the digestive drug Propulsid.
Superior Court Judge Marina Corodemus, who manages all mass-tort cases in the state courts, found that the case would involve too many individual issues. “Prescription drugs are not meant to work the same for everyone,” wrote Corodemus in a 36-page opinion, Cartiglia v. Johnson & Johnson. “This court cannot simply certify a class with this many variables. The plaintiffs have not drawn the class lines clearly enough.”
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
